TCL Archive NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ October 24, 1997
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest. November 22, 2006